Wistar Institute develops long-acting obesity drug delivery method in murine models

Researchers have engineered a method to induce endogenous production of weight-loss and glucose-regulating compounds, achieving 70-day efficacy in mice. The transition from preclinical animal models to human clinical trials remains uncertain, but the technology represents a potential shift from weekly injectable regimens.